Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle 7-related protein kinase (CDC7) is a serine/threonine kinase localized to the nucleus that plays a critical role in initiating DNA replication during the cell cycle. CDC7 functions as a key regulator of the G1/S phase transition by phosphorylating essential substrates including MCM proteins and CLASPIN, thereby controlling the initiation of DNA synthesis. As a fundamental component of replication control, CDC7 represents a therapeutic target for cancer treatment, with multiple investigational inhibitors and modulators currently in development, including compounds such as Simurosertib, PHA-767491, and BMS-863233. The kinase's essential role in DNA replication makes it particularly relevant for targeting rapidly dividing cancer cells.
Inhibitor and modulator
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle 7-related protein kinase (CDC7) (CDC7).